BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16061116)

  • 1. The mobilization of CD34 positive mononuclear cells after myocardial infarction is abolished by revascularization of the culprit vessel.
    Müller-Ehmsen J; Scheid C; Grundmann F; Hirsch I; Turan G; Tossios P; Mehlhorn U; Schwinger RH
    Int J Cardiol; 2005 Aug; 103(1):7-11. PubMed ID: 16061116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.
    Wojakowski W; Tendera M; Michałowska A; Majka M; Kucia M; Maślankiewicz K; Wyderka R; Ochała A; Ratajczak MZ
    Circulation; 2004 Nov; 110(20):3213-20. PubMed ID: 15533859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
    Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
    Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stem cell mobilization after coronary artery bypass grafting].
    Gaspardone A; De Fabritiis P; Scaffa R; Nardi P; Palombi F; Versaci F; Chiariello L
    Ital Heart J Suppl; 2004 Jan; 5(1):23-8. PubMed ID: 15253141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B
    Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
    Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional capacity in patients after myocardial infarction dependent on treatment strategy in acute phase of disease].
    Lakusić N; Mahović D; Cerovec D; Baborski F; Majsec M
    Acta Med Croatica; 2005; 59(4):341-5. PubMed ID: 16334743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
    Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
    Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure?].
    Katayama N; Horiuchi K; Nakao K; Kasanuki H; Honda T
    J Cardiol; 2005 Jul; 46(1):1-8. PubMed ID: 16095225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
    Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
    Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.
    Valgimigli M; Rigolin GM; Cittanti C; Malagutti P; Curello S; Percoco G; Bugli AM; Della Porta M; Bragotti LZ; Ansani L; Mauro E; Lanfranchi A; Giganti M; Feggi L; Castoldi G; Ferrari R
    Eur Heart J; 2005 Sep; 26(18):1838-45. PubMed ID: 15860518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.
    Deng Z; Yang C; Deng H; Yang A; Geng T; Chen X; Ma A; Liu Z
    Int J Cardiol; 2006 Oct; 113(1):92-6. PubMed ID: 16891014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.
    Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F
    Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction].
    Deng ZR; Yang C; Ma AQ; Chen XY; Geng T
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1637-40. PubMed ID: 17121721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy.
    Assali AR; Teplitsky I; Ben-Dor I; Solodky A; Brosh D; Battler A; Fuchs S; Kornowski R
    Am Heart J; 2007 Feb; 153(2):231-7. PubMed ID: 17239681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.